Abstract
Risk of COVID-19 in dermatologic patients receiving long-term immunomodulatory therapy
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.jaad.2020.06.999
Copy DOIPublication Date: Jul 2, 2020 | |
Citations: 18 | License type: other-oa |
Risk of COVID-19 in dermatologic patients receiving long-term immunomodulatory therapy
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.